DR. BRUSSELLE
ActiveSummary
The computed 12-month bankruptcy probability of DR. BRUSSELLE is 7.1% (elevated). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Articles of association
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Beperkt tot duur medische activiteiten bij meerdere hernieuwbare periode 6 jaar…” (deed in Dutch)“Vergoeding van de bestuurders, al dan niet ten kosteloze titel” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Werkelijke_waarde_op_dag_overdracht_zonder_patiëntenbestand, helft overdrager helft kopers naar evenredigheid verworven aantal” (deed in Dutch)
Meetings and financial year
- Financial yearThe twelve-month period the company draws up its annual accounts for.
- From 1 July to 30 June
- First financial yearThe first financial year after incorporation can be shorter or longer than twelve months.
- First financial year to 30-06-2026, first annual accounts due by 31-01-2027
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Tuesday of December at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, ontbinding op elk moment” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Naleving voorwaarden Wetboek van vennootschappen en verenigingen, beroep op artsen voor zaken persoonlijke levenssfeer patiënten en/of…” (deed in Dutch)1 more provision on this in the deed